Additionally, several cancer drivers that are Hsp90/Cdc37 client proteins—for example, hormone receptors, HER2, BCR-ABL, B-Raf and Src—were to some extent demonstrated to predict the response to drug treatment [10]. Here, ERBB2 is linked to cancer.